Meet Our Leadership Team
Our multi-disciplinary team of scientists, entrepreneurs, and technologists have united to create the future of precision neurology diagnostics. We are dedicated to building a next-generation digital biomarkers platform that could revolutionize the field.
Through the power of our proprietary machine-learning and augmented-reality technology, we are developing a precision neurology platform intended to redefine the industry standard. With our exceptional partner operations and platform delivery functions, we are continuously striving to redefine what it means to deliver a best-in-class service.
Our mission extends beyond simply offering solutions - we strive to make a transformative impact on healthcare within the field of neurological disease. By pushing the boundaries of what is possible, we hope to pave the way for a new era in healthcare and scale our industry-defining solutions to improve the lives of countless individuals, their families and healthcare providers.
Marc Jones
CEO and Board Director
Marc is the Chief Executive Officer at Altoida. He is a healthcare technology business leader with more than 25 years of experience across both private and publicly-held companies.
Prior to Altoida, Marc served as the Chief Operating Officer (COO) and Chief Financial Officer (CFO) of binx health, a digital health and molecular diagnostics company, where he co-founded binx's digital health business. At binx, he led the company through a critical phase of expansion from early to late-stage commercial product launch, generating multi-million revenue growth under his leadership. Marc also served as the COO and CFO of Good Start Genetics, which was acquired by Invitae (NVTA). As the inaugural CFO of T2 Biosystems (NASDAQ:TTOO), he played a fundamental role in navigating the company to a successful IPO.
Marc was also CFO of Crashlytics, where he oversaw the company's acquisition by Twitter in 2013. Prior to Crashlytics, he was CFO of Ivenix (acquired by Fresenius), and also CFO of CHiL Semiconductor, which was acquired by International Rectifier (now Infineon). Prior to CHiL, Marc held roles of increasing responsibility at Picis Inc. He has raised hundreds of millions in capital and has delivered multiple M&A transactions providing value to shareholders. Marc serves on the Board of Directors of Altoida, Progentec Diagnostics and Pathfinder Health.
Ioannis Tarnanas, Ph.D.
Co-founder and Chief Scientific Officer
Ioannis is a co-founder and Chief Scientific Officer at Altoida. Ioannis’ research focuses on using new technologies to understand the aging process and to establish prevention methods that decrease the risk of developing dementia or delay the onset of the disease. Ioannis has developed models and screens of dementia using computerized tests of complex, real-life activities, such as a novel assessment of spatial navigation and movement trajectory. With this technology, Ioannis is developing a predictive tool based on cognitive and non-cognitive biomarkers of early onset dementia.
At Altoida, Ioannis will pursue his development of computational biomarkers of Alzheimer’s disease. He is also working with local and international Alzheimer advocacy organizations to develop a responsible strategy to implement this technology and enable machine intelligence for disease prevention
Matt Gorman
Chief Financial Officer
Matt Gorman is a CFO for high growth companies in the life sciences. He is the Founder and Owner of CFgO, a finance, accounting, and strategy group supporting high growth companies. Working as a strategic partner with the CEO and management teams, Matt supports and guides companies through significant value inflection points including equity and debt financings, corporate partnering, IPO support, and M&A support. Matt has more than a decade of experience in leadership roles in the life sciences industry and previously worked for Fortune 50 and publicly traded companies. Matt is a certified public accountant and holds a B.A in accounting from Stonehill College and an M.B.A. from the University of Massachusetts Isenberg School of Management.
Nivaldo Diaz
VP, Software Product Development
Nivaldo is VP of Software Product Development at Altoida. He brings over 35 years’ experience in software engineering, including over 20 years in Healthcare Information Technology (HCIT). Nivaldo has led large, geographically distributed teams in the design and development of commercial HCIT platforms and products for hospitals across the globe, supporting solutions for Medication Management, electronic surveillance for Healthcare Associated Infections, Perioperative workflow, mobile point-of-care, health informatics using machine learning, and data / system integration. Nivaldo is an accomplished executive, adept at driving vision, strategy and execution of technological transformation in software organizations, having held leadership positions in product development and consulting services in startups and large enterprise settings across various industries covering public sector, telecommunications, and travel.
Marie McDonald
VP of Sales and Customer Success
Marie is Vice President, Sales and Customer Success at Altoida. Prior to joining Altoida, Marie was a member of IQVIA’s Real World Solutions North American Leadership Team, where she served as the leader of the Patient-Centered Solutions Team. Marie’s background is in management and strategy consulting within the life sciences industry. She worked in sales and delivery leadership roles for IQVIA and Clarkston Consulting, and she began her career as a pharmaceutical sales representative for Eli Lilly. Marie earned an undergraduate degree in Business from Shippensburg University and a Master of Science in career and technical education from Virginia Tech.